AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy
In the context of future adeno-associated viral (AAV)-based clinical trials for Duchenne myopathy, AAV genome fate in dystrophic muscles is of importance considering the viral capsid immunogenicity that prohibits recurring treatments. We showed that AAV genomes encoding non-therapeutic U7 were lost...
Main Authors: | Le Hir, M, Goyenvalle, A, Peccate, C, Précigout, G, Davies, K, Voit, T, Garcia, L, Lorain, S |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2013
|
פריטים דומים
-
AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
מאת: Goyenvalle, A, et al.
יצא לאור: (2010) -
AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
מאת: Goyenvalle, A, et al.
יצא לאור: (2011) -
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
מאת: Goyenvalle, A, et al.
יצא לאור: (2012) -
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
מאת: Goyenvalle, A, et al.
יצא לאור: (2012) -
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice
מאת: Philippine Aupy, et al.
יצא לאור: (2020-06-01)